Table 3.
Multivariable Cox regression predicting post-transplant survival.
O.R. | 95% C.I. | P value | |
---|---|---|---|
Induction (Basiliximab) | 1.41 | 1.06 - 1.87 | 0.02 |
Diagnosis-Obstructive | ref | ref | ref |
Diagnosis-Pulmonary hypertension | 0.75 | 0.42 - 1.35 | 0.34 |
Diagnosis-Suppurative | 0.68 | 0.45 - 1.02 | 0.06 |
Diagnosis-Restrictive | 1.02 | 0.78 - 1.34 | 0.89 |
Lung allocation score | 1 | 0.99 - 1.00 | 0.24 |
Recipient CMV positive | 1.49 | 1.11 - 2.00 | 0.01 |
CMV Mismatch | 1.13 | 0.79 - 1.62 | 0.51 |
Oncology history | 1.2 | 0.85 - 1.68 | 0.3 |
Any grade 3 primary graft dysfunction Within 72 Hours | 1.21 | 0.93 - 1.58 | 0.16 |
Treatment acute cellular rejection in First Year | 0.84 | 0.67 - 1.06 | 0.13 |
Postoperative hepatic dysfunction | 2.2 | 1.62 - 2.99 | < 0.001 |
Acute kidney injury requiring renal replacement therapy | 2.27 | 1.73 - 2.98 | < 0.001 |
Odds ratio for death are reported (OR>1 implies an increased risk of death).